The ALLFTD Bibliography:

The links below contain citations for all articles linked to the ALLFTD, ARTFL, LEFFTDS, and 4RTNI grants for funding. This includes both directly related (using data from the grants) and indirectly related (e.g. investigator partially supported by the grants).

Click here to continue to the PubMed search results for ALLFTD, ARTFL, and LEFFTDS!

Click here to continue to the PubMed search results for 4RTNI!

 
A&D Special Issue.png

Alzheimer’s & Dementia Special Issue on FTLD

The Alzheimer’s and Dementia Special Issue is a collection of 11 papers in FTLD and is a compilation of research from ARTFL and LEFFTDS.

Thank you to all involved in this effort (research study participants and their families, investigators, scientists, etc.), we are extremely thrilled with the research published in this special issue!

 

Recent Publications:

  1. Thijssen, E. H. et al. Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. Nature Medicine 26, 387-397, doi:10.1038/s41591-020-0762-2 (2020).

  2. Chen, Q. et al. Brain MR Spectroscopy Changes Precede Frontotemporal Lobar Degeneration Phenoconversion in MAPT Mutation Carriers. Journal of Neuroimaging 29, 624-629, doi:10.1111/jon.12642 (2019).

  3. Staffaroni A, et al. Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration. Alzheimer's & Dementia. 16, 37-48, doi:10.1016/j.jalz.2019.04.007 (2020).

 

Key Publications

  1. Boeve, B. et al. The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology. Alzheimer's & Dementia 16(1):22-36. doi: 10.1016/j.jalz.2019.06.4947 (2020).

  2. Boxer, A. L. et al. New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures. Alzheimer's & Dementia 16(1):131-143. doi: 10.1016/j.jalz.2019.06.4956 (2020).

  3. Moore, K. M. et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurology 19(2):145-156. doi: 10.1016/S1474-4422(19)30394-1. (2020).

  4. Rosen, H. J., Boeve, B. F. & Boxer, A. L. Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS. Alzheimer's & Dementia 16, 71-78, doi:10.1002/alz.12004 (2020).

  5. Thijssen, E. H. et al. Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. Nature Medicine 26, 387-397, doi:10.1038/s41591-020-0762-2 (2020).